When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Aclaris Therapeutics (NASDAQ:ACRS) is up 19.9% after hours following positive results from its Phase 1 trial of ATI-450, an investigational oral MK2 inhibitor.
More news on: Aclaris Therapeutics, Inc., Healthcare stocks news, Stocks on the move,